Chinese peripheral intravenous catheter market is anticipated to grow at a CAGR of 7.5% by 2023, according to a new report published by Gen Consulting Company. The report segments the market and forecasts its size, by volume and value, on the basis of application (hospitals & clinics, homecare, etc.), and by geography (North China, Northeast China, East China, South Central China, Southwest China, Northwest China).
The report covers forecast and analysis for the Peripheral Intravenous Catheter market. The study provides historic data of 2013-2017 along with a forecast from 2018 to 2023 based on both output/volume and revenue. The study then describes the drivers and restraints for the Peripheral Intravenous Catheter market along with the impact they have on the demand over the forecast period.
The report has been prepared based on the synthesis, analysis, and interpretation of information about the Chinese Peripheral Intravenous Catheter market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.
The research report provides analysis and information according to market segments such as geographies, types and applications. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in Chinese Peripheral Intravenous Catheter market.
Key Applications
- Hospitals & Clinics
- Homecare
Key Regions
- North China
- Northeast China
- East China
- South Central China
- Southwest China
- Northwest China
Key Vendors
- B. Braun
- Becton Dickinson
- Shandong Weigao
- Suzhou Linhua Medical
- Jiangxi Sanxin Medtec
- Yuwell
- request free sample to get a complete list of companies
Key Questions Answered in this Report
- What will the market size be in 2023?
- What are the key factors driving the Chinese Peripheral Intravenous Catheter market?
- What are the challenges to market growth?
- Who are the key players in the Peripheral Intravenous Catheter market?
- What are the market opportunities and threats faced by the key players?
Part 1. Summary
Part 2. Report Methodology
2.1 Methodology
2.2 Data Source
2.3 Disclaimer
Part 3. Market Overview
3.1 General Information
3.2 Segmentation by Application
3.2.1 Overview
3.2.2 Chinese Peripheral Intravenous Catheter Market by Application
3.3 Regional Peripheral Intravenous Catheter Market Size (Status & Prospect)
Part 4. Competitive Landscape
4.1 Chinese Peripheral Intravenous Catheter Sales & Share by Company (2013-2018)
4.2 Chinese Peripheral Intravenous Catheter Revenue & Share by Company (2013-2018)
4.3 Price Trends
4.4 Competitive Trends
Part 5. Segmentation by Application
5.1 Chinese Peripheral Intravenous Catheter Sales Volume by Application (2013-2018)
5.2 Chinese Peripheral Intravenous Catheter Revenue by Application (2013-2018)
5.3 Chinese Peripheral Intravenous Catheter Price by Application (2013-2018)
Part 6. Regional Perspectives
6.1 North China
6.2 Northeast China
6.3 East China
6.4 South Central China
6.5 Southwest China
6.6 Northwest China
Part 7. Company Profiles
7.1 Company Profile
7.2 Product Offered
7.3 Business Performance (2013-2018)
Part 8. Market Forecast
8.1 Chinese Peripheral Intravenous Catheter Market Size Forecast (2018-2023)
8.1.1 Chinese Peripheral Intravenous Catheter Sales Forecast (2018-2023)
8.1.2 Chinese Peripheral Intravenous Catheter Revenue Forecast (2018-2023)
8.2 Forecast by Region
8.3 Forecast by Application
Part 9. Industry Value Chain
9.1 Peripheral Intravenous Catheter Industry Value Chain Analysis
9.2 Upstream Raw Materials
9.3 End-users & Customers
9.4 Distributors
Part 10. Market Drivers
10.1 Rising Demand
10.2 Entry Barrier
10.3 Economic/Political Environmental
Electroceuticals are gaining attention as a non-invasive neuromodulation method with the advantages of low risk and low cost, replacing risky and costly invasive brain stimulation. In particular, it is expected to be a safe and effective treatment for treatment-resistant patients who have adverse re...
As of 2022, the total market size of intraocular lenses in Korea is estimated to be approximately ***units (***USD) by manufacturers'/importers' initial selling unit and ***units (***USD) by medical institutions' purchase unit.
It is estimated that the relatively high production/import volume...
In this report, medical AI is defined as artificial intelligence used across the healthcare industry. AI-enabled medical devices are in particular referred to devices which assist healthcare providers in diagnosing, managing and/or predicting diseases through analyzing medical big data with artifici...
The new DRG is a mixed payment method in which the NHIS pays for medical expenses incurred during a single medical treatment, dividing the cost of procedures, drugs, and therapeutic materials into all-inclusive and non-inclusive fees.
Most medical services are comprehensively bundled together...
As of 2022, the total market size of the wound dressings in Korea is estimated to be approximately USD *** million, about an increase of ***% compared to the previous year. Reimbursement volume is estimated to be approximately USD *** million - around ***% of the entire market.
Afterwards, it...
As defined by the FDA, Digital Therapeutics (DTx) is a "Software as a Medical Device (SaMD) that provides evidence-based therapeutic interventions to non-patients for the purpose of preventing, managing, or treating a medical disorder or disease based on biometric information collected from general-...
In 2022, the total market size of dental implants in Korea is estimated to be approxiamately USD ***million at manufacturers/importers' initial selling prices (about *** units, including fixtures and upper parts) and USD *** million at medical institutions' purchase prices.
The dental implants...
Dermal fillers are classified by the MFDS as Class Ⅳ medical devices, with the product classification number B04230.01 (biomaterial graft/prosthesis) or B04230.02 (graft/prosthesis).
According to the , dermal fillers are non-rei...
In 2022, the total market size of anti-adhesion products in Korea is estimated to be approximately USD *** million (manufacturers/importers' initial selling prices) and USD *** million (medical institutions' purchase prices).
While some estimates put the market size at around USD *** million ...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...